Market revenue in 2023 | USD 45.9 million |
Market revenue in 2030 | USD 105.9 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Medical |
Fastest growing segment | Dental |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Medical, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product |
Key market players worldwide | EnvisionTEC, Organovo Holdings Inc, 3D Systems Corp, Inventia Life, Poietis, Vivax Bio, Cyfuse Biomedical, Cellink, Regemat 3D |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d bioprinting market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 38.56% in 2023. Horizon Databook has segmented the Mexico 3d bioprinting market based on dental, medical, biosensors, consumer/personal product testing, bioinks, food and animal product covering the revenue growth of each sub-segment from 2018 to 2030.
The significant growth of Mexico's 3D bioprinting market in recent years can be attributed to several key drivers, such as the rising demand for personalized medical solutions, which has spurred the adoption of 3D bioprinting technology. This innovative approach enables the development of customized tissue & organ replacements, effectively addressing specific patient needs and improving treatment outcomes.
In addition, the increasing prevalence of chronic diseases, such as diabetes and organ failure, has created an urgent need for organ transplantation. However, the need for more organ donors presents a significant challenge. In response, 3D bioprinting has emerged as a promising alternative for producing functional organs suitable for transplantation.
For instance, in the first quarter of 2023, Mexico reported 636 organ and tissue transplant procedures, marking a remarkable surge of over 44% compared to 2022. Mexico has been making substantial advancements in organ transplantation, boasting a network of 442 licensed establishments dedicated to procurement, transplantation, and tissue banking as of 2022.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico 3d bioprinting market , including forecasts for subscribers. This country databook contains high-level insights into Mexico 3d bioprinting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account